Review International journal of molecular sciences · 2026 Microbiome-Immune Interactions as Determinants of Checkpoint Inhibitor Efficacy in Hepatocellular Carcinoma. Ostafe MR, Volovat SR, Clement A, et al. Akkermansia muciniphila PubMed ↗
Review Frontiers in cellular and infection microbiology · 2026 From dysbiosis to malignancy: decoding gut-driven pathways to clinical management in hepatocellular carcinoma. Ismaiel A, Almonajjed MB, Wardeh M, et al. Akkermansia muciniphila PubMed ↗
Observational Digestive and liver disease · 2026 Genetically predicted gut bacteria, circulating bacteria-associated metabolites and liver cancer: A Mendelian randomisation study. Daniel N, Papadimitriou N, Chatziioannou AC, et al. Agathobacter rectalis PubMed ↗
Review Cancer biology & medicine · 2026 How the gut microbiome affects the immunotherapy response in hepatocellular carcinoma. Wu M, Zhang Y, Yu J Akkermansia muciniphilaKlebsiella pneumoniae PubMed ↗
Observational Journal of gastroenterology and hepatology · 2026 Gut Microbiome Signatures Differ in Cirrhosis With and Without Hepatocellular Carcinoma in a Southeast Asian Cohort. Jinato T, Sikaroodia M, Gilleveta PM, et al. Mediterraneibacter gnavus PubMed ↗
Observational Clinical and translational gastroenterology · 2025 Fecal Microbiota and Bile Acid Profiles in Early-Stage Hepatocellular Carcinoma: A Matched Case-Control Study. Nobel YR, Park H, Tillman AM, et al. Klebsiella pneumoniae PubMed ↗
Review International journal of surgery · 2025 Gut microbiota-mediated oncogenesis in hepatocellular carcinoma: a new avenue for therapeutic intervention. Ramesh A, Subbarayan R, Srinivasan D, et al. Enterococcus faecalisEscherichia coli PubMed ↗
Review Current oncology · 2025 Akkermansia muciniphila and HCC: A Gut Feeling. Capasso M, Sanduzzi-Zamparelli M, Cossiga V, et al. Akkermansia muciniphila PubMed ↗
Review Toxins · 2025 Comprehensive Review of Dietary Probiotics in Reducing Aflatoxin B1 Toxicity. Choi D, Fan X, Yu JH Lactococcus lactis PubMed ↗
Observational Cell reports. Medicine · 2025 Phocaeicola vulgatus induces immunotherapy resistance in hepatocellular carcinoma via reducing indoleacetic acid production. Zhao CN, Li SS, Yau T, et al. Phocaeicola vulgatus PubMed ↗
Review Frontiers in immunology · 2025 Big lessons from the little Akkermansia muciniphila in hepatocellular carcinoma. Yang Y, Shi X Akkermansia muciniphila PubMed ↗
Review Biomolecules · 2021 Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Vallianou N, Christodoulatos GS, Karampela I, et al. Akkermansia muciniphilaFaecalibacterium prausnitziiSegatella copri PubMed ↗
Observational Nature reviews. Gastroenterology & hepatology · 2021 E. faecalis promotes liver carcinogenesis. Ray K Enterococcus faecalis PubMed ↗
Journal of extracellular vesicles · 2026 Enterococcus faecalis Extracellular Vesicles Deliver the Bacterial GTPase Obg to Hijack mTOR Signalling in Hepatocellular Carcinoma. Ma N, Xie X, Wang J, et al. Enterococcus faecalis PubMed ↗
Frontiers in immunology · 2026 Stress accelerates hepatocellular carcinoma progression via a gut microbial-metabolite axis. Hu Z, Yue P, Yuan M, et al. Phocaeicola vulgatus PubMed ↗
Journal of extracellular vesicles · 2026 Gut Commensal Klebsiella pneumoniae Extracellular Vesicles Shape a Liver Microenvironment Conducive to Gut-Liver Bacterial Translocation and Pro-Tumorigenic Processes. Tsubaki S, Nashimoto S, Tanaka R, et al. Klebsiella pneumoniae PubMed ↗
Cellular signalling · 2026 Functional and metabolic dysbiosis of the gut microbiome in the tumoral immune microenvironment of hepatocellular carcinoma. He Q, Wu H, Guo M, et al. Streptococcus salivarius PubMed ↗
Cell host & microbe · 2026 Intratumoral bacterium Enterocloster bolteae promotes hepatocellular carcinoma progression by directly binding tumor cells. Ren X, Zheng G, Liu Y, et al. Enterocloster bolteae PubMed ↗
Journal for immunotherapy of cancer · 2026 Modulating Bacteroides to boost anti-PD-1 immunotherapy in HCC. Qi X, Yang M, Liu X, et al. Bacteroides thetaiotaomicron PubMed ↗
NPJ biofilms and microbiomes · 2025 Deconjugating taurocholic acid with Bifidobacterium to mitigate obesity-driven cancer progression by restoring CD8+ T-cell infiltration. Yuan R, Li Y, Wang Y, et al. Bifidobacterium breve PubMed ↗